45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
3,213
Insurances with rates
5
CPT / HCPCS codes
3,202
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9347 | TREMELIMUMAB-ACTL 300MG/15ML | $51,554 | $38,665 | — | — | 9 |
| J9119 | CEMIPLIMAB 350 MG VIAL | $40,859 | $30,644 | — | — | 9 |
| J9043 | CABAZITAXEL 60 MG VIAL | $40,410 | $30,308 | — | — | 9 |
| J9228 | IPILIMUMAB 50 MG VIAL | $33,675 | $25,256 | — | — | 9 |
| J1162 | DIGOXIN IMMUNE FAB 40 MG VIAL | $30,593 | $22,945 | — | — | 9 |
| J9223 | LURBINECTEDIN 4 MG VIAL | $29,778 | $22,333 | — | — | 9 |
| J1300 | ECULIZUMAB 300 MG VIAL | $29,284 | $21,963 | — | — | 9 |
| J9301 | OBINUTUZUMAB 1000 MG VIAL- PER | $28,978 | $21,734 | — | — | 9 |
| J9022 | ATEZOLIZUMAB 840 MG VIAL | $28,894 | $21,671 | — | — | 9 |
| J3101 | TENECTEPLASE 50 MG VIAL | $28,877 | $21,658 | — | — | 9 |
| J2323 | NATALIZUMAB 300 MG VIAL | $28,719 | $21,540 | — | — | 9 |
| J3380 | VEDOLIZUMAB 300 MG VIAL | $28,193 | $21,145 | — | — | 9 |
| J9144 | DARATUMUMAB-HYALURONIDASE 1800 | $25,751 | $19,314 | — | — | 9 |
| J9306 | PERTUZUMAB 420 MG/14 ML VIAL | $22,498 | $16,873 | — | — | 9 |
| J9271 | PEMBROLIZUMAB 100 MG VIAL | $21,188 | $15,891 | — | — | 9 |
| J9356 | TRASTUZUMAB-HYALURONIDAS 600MG | $20,916 | $15,687 | — | — | 9 |
| J9298 | NIVOLUMAB-RELATLIMAB-RNBW | $18,824 | $14,118 | — | — | 9 |
| J2350 | OCRELIZUMAB 300 MG VIAL | $17,442 | $13,082 | — | — | 9 |
| Q5122 | PEGFILGRASTIM-APGF | $17,051 | $12,788 | — | — | 9 |
| J9207 | IXABEPILONE 45 MG VIAL | $15,138 | $11,353 | — | — | 9 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG VIAL | $14,325 | $10,744 | — | — | 9 |
| J1306 | INCLISIRAN 284 MG/1.5 ML | $14,224 | $10,668 | — | — | 9 |
| J2353 | OCTREOTIDE LAR 10 MG | $13,798 | $10,348 | — | — | 9 |
| J2426 | PALIPERIDONE PALMITATE 273MG | $13,723 | $10,292 | — | — | 9 |
| J9204 | MOGAMULIZUMAB-KPKC- 20 MG VIAL | $13,237 | $9,927 | — | — | 9 |
| J0717 | CERTOLIZUMAB PEGOL- 200 MG SYR | $11,644 | $8,733 | — | — | 9 |
| J2182 | MEPOLIZUMAB 100 MG VIAL | $11,521 | $8,641 | — | — | 9 |
| J9177 | Enfortumab Vedotin-ejfv 20mg | $11,417 | $8,563 | — | — | 9 |
| J9205 | IRINOTECAN LIPOSOMAL 43 MG | $11,098 | $8,323 | — | — | 9 |
| J9272 | DOSTARLIMAB-GXLY 500MG (JER) | $11,074 | $8,306 | — | — | 9 |
| J2182 | MEPOLIZUMAB 100MG VIAL -NUCALA | $10,971 | $8,228 | — | — | 9 |
| J1437 | FERRIC DERISOMALTOSE 1000MG | $10,430 | $7,823 | — | — | 9 |
| J9354 | ADO -TRASTUZUMAB 100 MG | $10,206 | $7,654 | — | — | 9 |
| J9033 | BENDAMUSTINE 100 MG | $10,008 | $7,506 | — | — | 9 |
| J1930 | LANREOTIDE 120 MG SYRINGE | $9,847 | $7,385 | — | — | 9 |
| J9353 | MARGETUXIMAB-CMBK 250MG/10ML | $9,623 | $7,217 | — | — | 9 |
| J9176 | ELOTUZUMAB 300 MG per 1MG | $9,594 | $7,195 | — | — | 9 |
| J2327 | Risankizumab-rzaa 600 mg vial | $9,468 | $7,101 | — | — | 9 |
| Q4105 | ALLOGRAPH 2CM X 2CM IDRT | $9,420 | $7,065 | — | — | 9 |
| A9572 | IN-111 OCTREOSCAN DOSE | $8,865 | $6,649 | — | — | 9 |
| J2505 | PEGFILGRASTIM 6 MG KIT | $8,724 | $6,543 | — | — | 9 |
| 59510 | HOSP CESAREAN DELIVERY GLOBAL | $8,547 | $6,410 | — | — | 9 |
| J9316 | PHESGO 600 mg-600 mg-20,000 u | $8,441 | $6,330 | — | — | 9 |
| J9330 | TEMSIROLIMUS 30 MG VIAL | $8,263 | $6,197 | — | — | 9 |
| J1826 | INTERFERON BETA-1A 30 MCG/0.5 | $8,199 | $6,149 | — | — | 9 |
| J0578 | Buprenorphine (Brixadi) 64 mg | $7,645 | $5,734 | — | — | 9 |
| J0578 | Buprenorphine (Brixadi) 64 mg | $7,645 | $5,734 | — | — | 9 |
| 59400 | HOSP OBSTETRICAL CARE | $7,583 | $5,687 | — | — | 9 |
| J9023 | AVELUMAB 200MG/10 ML VIAL | $7,495 | $5,621 | — | — | 9 |
| 44207 | HOSP L COLECTOMY/COLOPROCTOSTO | $7,442 | $5,582 | — | — | 9 |
Showing top 50 of 3,213 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.